Cargando…
Phage Cocktail Targeting STEC O157:H7 Has Comparable Efficacy and Superior Recovery Compared with Enrofloxacin in an Enteric Murine Model
O157:H7 is the most important Shiga toxin-producing Escherichia coli (STEC) serotype in relation to public health. Given that antibiotics may contribute to the exacerbation of STEC-related disease and an increased frequency of antibiotic-resistant strains, bacteriophage (phage) therapy is considered...
Autores principales: | Wang, Yuxin, Subedi, Dinesh, Li, Jin, Wu, Jiaoling, Ren, Jianluan, Xue, Feng, Dai, Jianjun, Barr, Jeremy J., Tang, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241756/ https://www.ncbi.nlm.nih.gov/pubmed/35536028 http://dx.doi.org/10.1128/spectrum.00232-22 |
Ejemplares similares
-
Microencapsulated phages show prolonged stability in gastrointestinal environments and high therapeutic efficiency to treat Escherichia coli O157:H7 infection
por: Yin, Hanjie, et al.
Publicado: (2021) -
Sporadic STEC O157 infection: secondary household transmission in Wales.
por: Parry, S M, et al.
Publicado: (1998) -
Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study
por: Gordillo Altamirano, Fernando L., et al.
Publicado: (2022) -
Molecular Hazard Identification of Non-O157 Shiga Toxin-Producing Escherichia coli (STEC)
por: Franz, Eelco, et al.
Publicado: (2015) -
Pathogenicity Islands Distribution in Non-O157 Shiga Toxin-Producing Escherichia coli (STEC)
por: Soledad-Cadona, Jimena, et al.
Publicado: (2018)